Oscar Health, Inc.

This adjusted net income is then divided by the sum of the basic weighted-average shares of common stock outstanding and any dilutive potential common stock outstanding during the period, using the treasury stock method and the if-converted method for convertible senior notes, as described in Note 9 - Debt .

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

treasury and agency securities 48 $ 265,431 $ ( 445 ) 5 $ 40,784 $ ( 120 ) Corporate notes 59 82,246 ( 50 ) Total 107 $ 347,677 $ ( 495 ) 5 $ 40,784 $ ( 120 ) The Company monitors available-for-sale debt securities for credit losses and recognizes an allowance for credit losses when factors indicate a decline in the fair value of a security is credit-related.

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

DEBT 2031 Convertible Senior Notes In February 2022, the Company issued $ 305.0 million in aggregate principal amount of convertible senior notes due 2031 (the 2031 Notes ) in a private placement to funds affiliated with or advised by Dragoneer Investment Group, LLC, Thrive Capital, LionTree Investment Management, LLC, and Tenere Capital LLC (the Initial Purchasers ).

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

As discussed further below, in connection with the Exchange Agreement and the related transactions, as of November 5, 2025, the debt covenants in the Investment Agreement, as amended, were extinguished, and the 2030 Notes ceased to be subordinated to the 2031 Notes.

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

The 2031 Notes will mature on December 31, 2031, unless they are earlier repurchased, redeemed, or converted, as further discussed in Note 9 - Debt , in the Company s Annual Report on Form 10-K for the year ended December 31, 2025.

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

The holders may elect to convert their 2031 Notes if certain conditions are met, as further discussed in Note 9 - Debt, in the Company s Annual Report on Form 10-K for the year ended December 31, 2025, including upon the satisfaction of a Class A common stock sale price condition.

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026

These statements include, but are not limited to, statements about our financial outlook and estimates, including Total revenue, Medical Loss Ratio, SG A Expense Ratio, Earnings from Operations, and other financial performance metrics, and the related underlying assumptions, our business and financial prospects, including management s plans and objectives for future operations, expectations and business strategy, such as our 2026 pricing actions, and industry and market dynamics and expected trends.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

( Oscar ) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

News Release Key Operating and Non-GAAP Financial Metrics We regularly review the following key operating and Non-GAAP financial metrics, to evaluate our business, measure our performance, identify trends in our business, prepare financial projections, and make strategic decisions.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

It is a key indicator of the Company s profitability and operational efficiency, allowing management to evaluate performance and make informed decisions on strategic planning, cost management, and resource allocation.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

GAAP measure, Net income (loss), we believe we are enhancing investors understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control.

SEC original ↗Oscar Health, Inc. — Earnings release (8-K exhibit)EX-99Aug 6, 2025

Legal Proceedings 39 Item 1A.

SEC original ↗Oscar Health, Inc. — 10-Q Quarterly report10-QAug 7, 2026